These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21975435)

  • 1. Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors.
    Curran T; Tulin-Silver S; Patel K; Ward S; Schneiderman M; Harpaz N; Schwartz M; Itzkowitz S; Warner RR; Kim MK
    Pancreas; 2011 Nov; 40(8):1253-7. PubMed ID: 21975435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
    Burke AP; Thomas RM; Elsayed AM; Sobin LH
    Cancer; 1997 Mar; 79(6):1086-93. PubMed ID: 9070484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal carcinoid tumors.
    Eller R; Frazee R; Roberts J
    Am Surg; 1991 Jul; 57(7):434-7. PubMed ID: 2058850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors.
    Jensen EH; Kvols L; McLoughlin JM; Lewis JM; Alvarado MD; Yeatman T; Malafa M; Shibata D
    Ann Surg Oncol; 2007 Feb; 14(2):780-5. PubMed ID: 17146740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
    Korse CM; Bonfrer JM; Aaronson NK; Hart AA; Taal BG
    Neuroendocrinology; 2009; 89(3):296-301. PubMed ID: 18840995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
    Sökmensüer C; Gedikoglu G; Uzunalimoglu B
    Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
    Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
    Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors.
    Dhall D; Mertens R; Bresee C; Parakh R; Wang HL; Li M; Dhall G; Colquhoun SD; Ines D; Chung F; Yu R; Nissen NN; Wolin E
    Hum Pathol; 2012 Apr; 43(4):489-95. PubMed ID: 21937080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Ki-67 in predicting biological behavior of goblet cell carcinoid tumor in appendix.
    Liu E; Telem DA; Warner RR; Dikman A; Divino CM
    Am J Surg; 2011 Oct; 202(4):400-3. PubMed ID: 21824598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological features and prognosis of different gastric carcinoid subtypes].
    Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors.
    Arnold R; Wilke A; Rinke A; Mayer C; Kann PH; Klose KJ; Scherag A; Hahmann M; Müller HH; Barth P
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):820-7. PubMed ID: 18547872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
    Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
    In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus.
    Goto K; Kodama T; Matsuno Y; Yokose T; Asamura H; Kamiya N; Shimosato Y
    Mod Pathol; 2001 Oct; 14(10):985-94. PubMed ID: 11598168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients.
    Rugge M; Fassan M; Clemente R; Rizzardi G; Giacomelli L; Pennelli G; Mescoli C; Segat D; Rea F
    Clin Cancer Res; 2008 Jan; 14(1):149-54. PubMed ID: 18172265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.
    Cheville JC; Tindall D; Boelter C; Jenkins R; Lohse CM; Pankratz VS; Sebo TJ; Davis B; Blute ML
    Cancer; 2002 Sep; 95(5):1028-36. PubMed ID: 12209687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship of biological behavior and the prognosis in gastric carcinoid].
    Liu Y; Liang H; Liu N; Zhang RP; Cui QH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):472-5. PubMed ID: 17851792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.